{"entity":{"type":"insider","cik":"0001942597","url":"/insider/0001942597","json_url":"/insider/0001942597.json","name":"Poulton Stuart","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":17,"n_filings":13,"first":"2023-02-17","last":"2026-07-30","span_basis":"filed_date"},"name_variants":[{"name":"Poulton Stuart","source":"filing","n_filings":13,"first_seen":"2023-02-17","last_seen":"2026-07-30"}],"transactions":[{"id":5873545,"accession":"0001193125-26-326290","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-26-326290","line_url":"/filing/0001193125-26-326290#line-1","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":"0001942597","owner_name":"Poulton Stuart","owner_display_name":"Poulton Stuart","owner_url":"/insider/0001942597","role":"Officer (EVP, Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Development Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":189.0,"shares_display":"189","price_per_share":7.1,"price_display":"7.10","price_state":"stated","total_value":1341.9,"total_display":"1,341.90","total_whole":"1,342","shares_owned_after":94632.0,"shares_owned_after_display":"94,632","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-07-28","filed_date":"2026-07-30","scope":"insider"},{"id":6040404,"accession":"0001193125-26-226697","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193125-26-226697","line_url":"/filing/0001193125-26-226697#line-2","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":"0001942597","owner_name":"Poulton Stuart","owner_display_name":"Poulton Stuart","owner_url":"/insider/0001942597","role":"Officer (EVP, Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Development Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":403.0,"shares_display":"403","price_per_share":9.5,"price_display":"9.50","price_state":"stated","total_value":3828.5,"total_display":"3,828.50","total_whole":"3,829","shares_owned_after":94821.0,"shares_owned_after_display":"94,821","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-14","filed_date":"2026-05-15","scope":"insider"},{"id":5912783,"accession":"0001942597-26-000003","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001942597-26-000003","line_url":"/filing/0001942597-26-000003#line-1","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":"0001942597","owner_name":"Poulton Stuart","owner_display_name":"Poulton Stuart","owner_url":"/insider/0001942597","role":"Officer (EVP, Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Development Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5101.0,"shares_display":"5,101","price_per_share":9.4095,"price_display":"9.41","price_state":"stated","total_value":47997.8595,"total_display":"47,997.86","total_whole":"47,998","shares_owned_after":94328.0,"shares_owned_after_display":"94,328","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-02","filed_date":"2026-03-03","scope":"insider"},{"id":6228811,"accession":"0001193125-26-059332","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-26-059332","line_url":"/filing/0001193125-26-059332#line-1","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":"0001942597","owner_name":"Poulton Stuart","owner_display_name":"Poulton Stuart","owner_url":"/insider/0001942597","role":"Officer (EVP, Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Development Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":378.0,"shares_display":"378","price_per_share":8.63,"price_display":"8.63","price_state":"stated","total_value":3262.14,"total_display":"3,262.14","total_whole":"3,262","shares_owned_after":99429.0,"shares_owned_after_display":"99,429","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-17","filed_date":"2026-02-19","scope":"insider"},{"id":4170973,"accession":"0001193125-25-205046","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193125-25-205046","line_url":"/filing/0001193125-25-205046#line-2","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":"0001942597","owner_name":"Poulton Stuart","owner_display_name":"Poulton Stuart","owner_url":"/insider/0001942597","role":"Officer (EVP, Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Development Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":401.0,"shares_display":"401","price_per_share":6.43,"price_display":"6.43","price_state":"stated","total_value":2578.43,"total_display":"2,578.43","total_whole":"2,578","shares_owned_after":27710.0,"shares_owned_after_display":"27,710","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-09-15","filed_date":"2025-09-16","scope":"insider"},{"id":4912536,"accession":"0000950170-25-100373","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-100373","line_url":"/filing/0000950170-25-100373#line-1","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":"0001942597","owner_name":"Poulton Stuart","owner_display_name":"Poulton Stuart","owner_url":"/insider/0001942597","role":"Officer (EVP, Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Development Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":191.0,"shares_display":"191","price_per_share":4.37,"price_display":"4.37","price_state":"stated","total_value":834.67,"total_display":"834.67","total_whole":"835","shares_owned_after":27223.0,"shares_owned_after_display":"27,223","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-07-29","filed_date":"2025-07-30","scope":"insider"},{"id":4312213,"accession":"0000950170-25-034723","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-034723","line_url":"/filing/0000950170-25-034723#line-1","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":"0001942597","owner_name":"Poulton Stuart","owner_display_name":"Poulton Stuart","owner_url":"/insider/0001942597","role":"Officer (EVP, Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Development Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3548.0,"shares_display":"3,548","price_per_share":6.29,"price_display":"6.29","price_state":"stated","total_value":22316.92,"total_display":"22,316.92","total_whole":"22,317","shares_owned_after":27414.0,"shares_owned_after_display":"27,414","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-04","filed_date":"2025-03-06","scope":"insider"},{"id":4263350,"accession":"0000950170-25-023192","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-023192","line_url":"/filing/0000950170-25-023192#line-1","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":"0001942597","owner_name":"Poulton Stuart","owner_display_name":"Poulton Stuart","owner_url":"/insider/0001942597","role":"Officer (EVP, Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Development Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5914.0,"shares_display":"5,914","price_per_share":0.63,"price_display":"0.63","price_state":"stated","total_value":3725.82,"total_display":"3,725.82","total_whole":"3,726","shares_owned_after":320714.0,"shares_owned_after_display":"320,714","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-18","filed_date":"2025-02-19","scope":"insider"},{"id":3111710,"accession":"0000950170-24-088589","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-088589","line_url":"/filing/0000950170-24-088589#line-1","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":"0001942597","owner_name":"Poulton Stuart","owner_display_name":"Poulton Stuart","owner_url":"/insider/0001942597","role":"Officer (EVP, Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Development Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2883.0,"shares_display":"2,883","price_per_share":1.06,"price_display":"1.06","price_state":"stated","total_value":3055.98,"total_display":"3,055.98","total_whole":"3,056","shares_owned_after":326628.0,"shares_owned_after_display":"326,628","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-07-30","filed_date":"2024-07-31","scope":"insider"},{"id":2036985,"accession":"0000950170-24-025192","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-025192","line_url":"/filing/0000950170-24-025192#line-2","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":"0001942597","owner_name":"Poulton Stuart","owner_display_name":"Poulton Stuart","owner_url":"/insider/0001942597","role":"Officer (EVP, Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Development Officer","security_title":"Common","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6155.0,"shares_display":"6,155","price_per_share":1.2,"price_display":"1.20","price_state":"stated","total_value":7386.0,"total_display":"7,386.00","total_whole":"7,386","shares_owned_after":329511.0,"shares_owned_after_display":"329,511","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-01","filed_date":"2024-03-04","scope":"insider"},{"id":2036984,"accession":"0000950170-24-025192","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-025192","line_url":"/filing/0000950170-24-025192#line-1","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":"0001942597","owner_name":"Poulton Stuart","owner_display_name":"Poulton Stuart","owner_url":"/insider/0001942597","role":"Officer (EVP, Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Development Officer","security_title":"Common","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16311.0,"shares_display":"16,311","price_per_share":1.17,"price_display":"1.17","price_state":"stated","total_value":19083.87,"total_display":"19,083.87","total_whole":"19,084","shares_owned_after":335666.0,"shares_owned_after_display":"335,666","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-29","filed_date":"2024-03-04","scope":"insider"},{"id":2586421,"accession":"0000950170-24-017237","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-017237","line_url":"/filing/0000950170-24-017237","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":"0001942597","owner_name":"Poulton Stuart","owner_display_name":"Poulton Stuart","owner_url":"/insider/0001942597","role":"Officer (EVP, Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Development Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5847.0,"shares_display":"5,847","price_per_share":1.33118522319138,"price_display":"1.33","price_state":"stated","total_value":7783.44,"total_display":"7,783.44","total_whole":"7,783","shares_owned_after":163871.0,"shares_owned_after_display":"163,871","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-15","filed_date":"2024-02-20","scope":"insider","n_lines":2},{"id":8726522,"accession":"0001209191-23-044040","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-044040","line_url":"/filing/0001209191-23-044040#line-1","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":"0001942597","owner_name":"Poulton Stuart","owner_display_name":"Poulton Stuart","owner_url":"/insider/0001942597","role":"Officer (EVP, Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Development Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2845.0,"shares_display":"2,845","price_per_share":1.7,"price_display":"1.70","price_state":"stated","total_value":4836.5,"total_display":"4,836.50","total_whole":"4,837","shares_owned_after":156286.0,"shares_owned_after_display":"156,286","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-07-28","filed_date":"2023-08-01","scope":"insider"},{"id":8151614,"accession":"0001209191-23-010509","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-23-010509","line_url":"/filing/0001209191-23-010509","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":"0001942597","owner_name":"Poulton Stuart","owner_display_name":"Poulton Stuart","owner_url":"/insider/0001942597","role":"Officer (EVP, Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Development Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5869.0,"shares_display":"5,869","price_per_share":3.1890526495143976,"price_display":"3.19","price_state":"stated","total_value":18716.55,"total_display":"18,716.55","total_whole":"18,717","shares_owned_after":64335.0,"shares_owned_after_display":"64,335","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-15","filed_date":"2023-02-17","scope":"insider","n_lines":3}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":17,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":17,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":17},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001503802","name":"Karyopharm Therapeutics Inc.","url":"/issuer/0001503802","role":"Officer (EVP, Chief Development Officer)","n_filings":13,"first_seen":"2023-02-17","last_seen":"2026-07-30"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001942597","retrieved_at":"2026-08-25T05:39:58+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}